Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND.

Sanchez AB, Kaul M.

Brain Sci. 2017 Feb 23;7(3). pii: E25. doi: 10.3390/brainsci7030025. Review.

2.

Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity.

Bowyer JF, Hanig JP.

Temperature (Austin). 2014 Nov 14;1(3):172-82. doi: 10.4161/23328940.2014.982049. eCollection 2014 Oct-Dec. Review.

3.

Chronic Methamphetamine Effects on Brain Structure and Function in Rats.

Thanos PK, Kim R, Delis F, Ananth M, Chachati G, Rocco MJ, Masad I, Muniz JA, Grant SC, Gold MS, Cadet JL, Volkow ND.

PLoS One. 2016 Jun 8;11(6):e0155457. doi: 10.1371/journal.pone.0155457. eCollection 2016. Erratum in: PLoS One. 2017 Feb 8;12 (2):e0172080.

4.

Cocaine and methamphetamine induce opposing changes in BOLD signal response in rats.

Taheri S, Xun Z, See RE, Joseph JE, Reichel CM.

Brain Res. 2016 Jul 1;1642:497-504. doi: 10.1016/j.brainres.2016.04.040. Epub 2016 Apr 18.

PMID:
27103569
5.

Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.

Hellem TL, Sung YH, Shi XF, Pett MA, Latendresse G, Morgan J, Huber RS, Kuykendall D, Lundberg KJ, Renshaw PF.

J Dual Diagn. 2015;11(3-4):189-202. doi: 10.1080/15504263.2015.1100471.

6.

Glutamatergic neurometabolites during early abstinence from chronic methamphetamine abuse.

O'Neill J, Tobias MC, Hudkins M, London ED.

Int J Neuropsychopharmacol. 2014 Oct 31;18(3). pii: pyu059. doi: 10.1093/ijnp/pyu059.

7.

Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.

London ED, Kohno M, Morales AM, Ballard ME.

Brain Res. 2015 Dec 2;1628(Pt A):174-85. doi: 10.1016/j.brainres.2014.10.044. Epub 2014 Nov 4. Review.

8.

Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.

Courtney KE, Ray LA.

Drug Alcohol Depend. 2014 Oct 1;143:11-21. doi: 10.1016/j.drugalcdep.2014.08.003. Epub 2014 Aug 17. Review.

9.

Functional and structural brain changes associated with methamphetamine abuse.

Jan RK, Kydd RR, Russell BR.

Brain Sci. 2012 Oct 1;2(4):434-82. doi: 10.3390/brainsci2040434.

10.

Perceived risk of methamphetamine among Chinese methamphetamine users.

Kelly BC, Liu T, Yang XY, Zhang G, Hao W, Wang J.

Int J Drug Policy. 2014 Nov;25(6):1076-83. doi: 10.1016/j.drugpo.2014.05.007. Epub 2014 May 21.

11.

The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans.

Taylor SB, Lewis CR, Olive MF.

Subst Abuse Rehabil. 2013 Feb 8;4:29-43. doi: 10.2147/SAR.S39684. eCollection 2013. Review.

12.

The effects of methylphenidate on cognitive control in active methamphetamine dependence using functional magnetic resonance imaging.

Jan RK, Lin JC, McLaren DG, Kirk IJ, Kydd RR, Russell BR.

Front Psychiatry. 2014 Mar 6;5:20. doi: 10.3389/fpsyt.2014.00020. eCollection 2014.

13.
14.

Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Howell LL, Negus SS.

Adv Pharmacol. 2014;69:129-76. doi: 10.1016/B978-0-12-420118-7.00004-4. Review.

15.

A voxel-based morphometry study of young occasional users of amphetamine-type stimulants and cocaine.

Mackey S, Stewart JL, Connolly CG, Tapert SF, Paulus MP.

Drug Alcohol Depend. 2014 Feb 1;135:104-11. doi: 10.1016/j.drugalcdep.2013.11.018. Epub 2013 Dec 1.

16.

Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study.

Li X, Malcolm RJ, Huebner K, Hanlon CA, Taylor JJ, Brady KT, George MS, See RE.

Drug Alcohol Depend. 2013 Dec 1;133(2):641-6. doi: 10.1016/j.drugalcdep.2013.08.012. Epub 2013 Aug 26.

17.

Methamphetamine and Parkinson's disease.

Granado N, Ares-Santos S, Moratalla R.

Parkinsons Dis. 2013;2013:308052. doi: 10.1155/2013/308052. Epub 2013 Feb 7.

18.

Decreased frontal lobe phosphocreatine levels in methamphetamine users.

Sung YH, Yurgelun-Todd DA, Shi XF, Kondo DG, Lundberg KJ, McGlade EC, Hellem TL, Huber RS, Fiedler KK, Harrell RE, Nickerson BR, Kim SE, Jeong EK, Renshaw PF.

Drug Alcohol Depend. 2013 Apr 1;129(1-2):102-9. doi: 10.1016/j.drugalcdep.2012.09.015. Epub 2012 Oct 18.

19.

Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.

Graham DL, Amos-Kroohs RM, Braun AA, Grace CE, Schaefer TL, Skelton MR, Williams MT, Vorhees CV.

Int J Neuropsychopharmacol. 2013 Mar;16(2):377-91. doi: 10.1017/S1461145712000144. Epub 2012 Mar 6.

20.

The impact of orbitofrontal dysfunction on cocaine addiction.

Lucantonio F, Stalnaker TA, Shaham Y, Niv Y, Schoenbaum G.

Nat Neurosci. 2012 Jan 22;15(3):358-66. doi: 10.1038/nn.3014. Review.

Supplemental Content

Support Center